Full text is available at the source.
Abstract
Stimuli-responsive solid lipid nanoparticles (SLNs) may enhance biofilm-targeted drug delivery.
- SLNs are designed to respond to specific stimuli, which may improve the targeting of drugs to biofilm-associated infections.
- Recent advances in SLN technology could provide new therapeutic options for challenging bacterial infections.
- The mechanisms by which SLNs operate involve the release of drugs in response to environmental changes.
- Future research may focus on optimizing SLN formulations for better efficacy in clinical settings.
Simplified